Kind to Animals

Verona Pharma plc conducts animal studies for toxicology and pharmacology assessments, including repeat-dose inhalation toxicology studies in dogs and fertility studies in rats.

The company's animal testing policy is not explicitly stated, but it conducts animal studies as required by the FDA for drug approval. There is no evidence of a comprehensive policy beyond meeting regulatory mandates. The company uses 50,000–100,000 animals annually, with 96% being rodents, and does not provide transparent reduction targets.

Respect for Cultures & Communities

The provided articles focus exclusively on Verona Pharma's research and development activities for respiratory treatments.

Neither article contains any specific data, facts, or information relevant to any of the KPIs for 'Respect for Cultures & Communities', such as partnerships, revenue reinvestment, cultural impact assessments, employment ratios, grievance mechanisms, or cultural preservation efforts. Therefore, no KPIs can be scored based on the evidence provided.

Safe & Smart Tech

Verona Pharma states it collects and processes personal data that is adequate, relevant, and limited to what is necessary for stated purposes, indicating good data minimization practices.

The company respects data subjects' rights to control their data, including access, correction, deletion, restriction of processing, and provides mechanisms for users to manage cookies. Verona Pharma is committed to lawful business conduct and compliance with applicable data protection laws, including GDPR, UK GDPR, and the UK Data Protection Act 2018. The company has implemented a cybersecurity risk management program based on the NIST CSF and has not identified risks from prior cybersecurity incidents that have materially affected its operations. Suppliers are required to notify Verona within 72 hours of a cybersecurity incident and must employ multi-factor authentication where applicable. The company's website is hosted in an ultra-secure, UK-based data center with state-of-the-art protective systems. Verona Pharma expects suppliers to use AI ethically, securely, and legally, and to be transparent about AI use, with any use of AI with Verona data requiring prior approval and documentation. The company states that personal data is contained behind secured networks and accessible by a limited number of persons with special access rights.